Déborah Eshagh
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
-
- COVID-19 and healthcare impacts
- CAR-T cell therapy research
Papers in
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
- SARS-CoV-2 detection and testing 1
- Tuberculosis Research and Epidemiology 1
-
- Systemic Sclerosis and Related Diseases 3
- Co-authors
- Khadija Benali (2 shared papers)T. Papo (2 shared papers)Karim Sacré (2 shared papers)Mohamad Mohty (2 shared papers)Guillaume Madelin (1 shared paper)Flore Rozenberg (1 shared paper)Florent Malard (2 shared papers)Tali‐Anne Szwebel (1 shared paper)
- Journals
- Blood (1 paper)PLoS ONE (1 paper)Clinical & Experimental Immunology (1 paper)Stem Cell Reviews and Reports (1 paper)Infection (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
Déborah Eshagh
10 papers receiving 409 citations
Peers
Comparison fields: 5 of 30
- Infectious Diseases 341
- Oncology 29
- Immunology 22
- Genetics 8
- Hematology 12
Countries citing papers authored by Déborah Eshagh
This map shows the geographic impact of Déborah Eshagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Déborah Eshagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Déborah Eshagh more than expected).
Fields of papers citing papers by Déborah Eshagh
This network shows the impact of papers produced by Déborah Eshagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Déborah Eshagh. The network helps show where Déborah Eshagh may publish in the future.
Co-authors
The 25 scholars most cited alongside Déborah Eshagh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 242 | |
| 2 | 2021 | 104 | |
| 3 | 2020 | 21 | |
| 4 | 2021 | 17 | |
| 5 | 2021 | 10 | |
| 6 | 2020 | 6 | |
| 7 | 2022 | 6 | |
| 8 | 2024 | 5 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 1 |
About Déborah Eshagh
Déborah Eshagh is a scholar working on Infectious Diseases, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Hematology and Surgery, having authored 10 papers that have together received 414 indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (3 papers), COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Vasculitis and related conditions (2 papers), SARS-CoV-2 detection and testing (1 paper), Tuberculosis Research and Epidemiology (1 paper), Platelet Disorders and Treatments (1 paper) and Infectious Diseases and Tuberculosis (1 paper). The work is most often cited by research in Infectious Diseases (341 citations), Oncology (29 citations), Immunology (22 citations), Genetics (8 citations) and Hematology (12 citations). Déborah Eshagh has collaborated with scholars based in France and United States. Frequent co-authors include Khadija Benali, T. Papo, Karim Sacré, Mohamad Mohty, Guillaume Madelin, Flore Rozenberg, Florent Malard, Tali‐Anne Szwebel, Solen Kernéis and Adrien Contejean. Their work appears in journals such as Blood, PLoS ONE, Clinical & Experimental Immunology, Stem Cell Reviews and Reports and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.